Delivery Order SPE2DB22D9367-SPE2DB25FTA01
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count). The contract is valued at approximately $24.2K with a firm fixed-price structure and an ultimate completion date of September 17, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500M through...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 6, 2025, is due for completion by August 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units) under a firm fixed-price contract valued at $12,146.79. The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units) under firm fixed-price terms. The contract, valued at $12,146.79 with an ultimate completion date of September 22, 2025, was awarded on September 19, 2025, with no set-aside designation applied. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This $12,115.65 firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and is not designated as a set-aside contract. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,179.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The contract, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.1K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packaging). The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FTA01Delivery Order
The Defense Logistics Agency awarded a $48.2 million delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count). This firm fixed-price delivery order, issued on September 22, 2025, with a completion date of September 23, 2025, was awarded without set-aside designation. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million single-award contract through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's extensive contract portfolio demonstrates expertise across diverse pharmaceutical categories, from specialty oncology treatments to vaccines and contraceptive devices. This delivery order for Jakafi, an oncology medication used in treatment of myelofibrosis and polycythemia vera, reflects the company's ongoing role in providing essential pharmaceutical inventory to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.2k | 9/22/25 |